Martha A. Grogan - Publications

Susceptibility and screening approaches in systemic amyloidosis: expert perspectives from the International Society of Amyloidosis (ISA).

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: September 04, 2026

Gene Silencer Therapy in Transthyretin Amyloid Cardiomyopathy: A Meta-Analysis of Outcomes Trials.

Journal: JAMA

Published: August 30, 2026

Utility of Prognostic Staging Systems in Transthyretin Amyloidosis Cardiomyopathy in the Era of Available Disease-Modifying Treatment.

Journal: Journal of the American Heart Association

Published: August 07, 2026

Effect of acoramidis on risk of death and heart problem-related hospitalizations in people with transthyretin amyloid cardiomyopathy: a plain language summary.

Journal: Future cardiology

Published: August 05, 2026

Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy.

Journal: Circulation. Cardiovascular imaging

Published: July 23, 2026

Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.

Journal: Journal of the American College of Cardiology

Published: June 22, 2026

Bioepidemiology of cardiac amyloidosis.

Journal: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology

Published: June 12, 2026

Prevalence and Burden of Cardiac Amyloidosis in a Population-Based Autopsy Cohort.

Journal: Circulation

Published: June 08, 2026

Sex Differences in a Contemporary, Real-World Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis.

Journal: Cardiology and therapy

Published: May 27, 2026

Artificial intelligence-enhanced electrocardiogram findings before and after heart transplantation in cardiac amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: May 18, 2026

Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CM.

Journal: Journal of cardiac failure

Published: May 08, 2026

Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CM.

Journal: Journal of cardiac failure

Published: May 08, 2026